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SUMMARY.-Three hundred and nineteen patients with primary adeno-
carcinoma of the ovary were studied to define those factors, many of them
histopathological, which influence survival. The paper considers the stage of
spread at the time of operation, the histological type of the tumour, its grade
and in particular its mitotic activity, which proved a significant feature per se
in assessing prognosis in ovarian cancer.
A SURVEY has been carred out on 319 patients with primary adenocarcinoma of
the ovary to evaluate some ofthe factors which influence survival in this disease.
It became apparent during the investigation that the mitotic count was of consid-
erable prognostic significance. Other factors considered were the histological
type ofthe tumour, the stage to which it had spread at the time of operation and
its histologicalgrade.
Ford (1928) was the first person to evaluate the prognosis according to the
stage of spread at the time of operation, and the first large series was published
in 1932 (Heyman, 1932). The first paper on grading appeqred at much the same
time (Taylor, 1929), and most series since that of Pemberton (1940) have treated
it as an important prognostic factor.
Although cellular atypicality, as a feature of malignancy, has been discussed
frequently in relation to grading, mitotic activity has received much less attention.
Barzilai (1943) reported that mitoses were "frequently seen " in the group of
tumours which she called " sero-anaplastic", and Allan and Hertig (1949) used
profusion of mitoses as one of the indicators of the most malignant neoplasms.
But at the time when this study was undertaken, no publication had been found
in which mitoses were considered as a separate feature. The only published work
specifically devoted to this point was by Novak and Woodruff (1967) after the
present investigation had been largely completed. It confirms that the count
of mitoses per high power field is of prognostic significance in carcinoma of the
ovary.
MATERIALS AND METHODS
The material for this survey came from 319 patients at four hospitals.
Hospital Years Cases
The Middlesex Hospital, London 1946-62 138
The Hospital for Women, Soho Square, London 1943-62 94
The Hospital for Women, Chelsea, London 1956-61 53
The Whittington Hospital, London 1952-61 34
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Criteriafor selection.-Since it was decided to make this series as homogeneous
as possible, patients were included only if they had a primary adenocarcinoma of
the ovary. Tumours metasatic to the ovary or whose origin was doutbful were
excluded, andbiopsy material was acceptable onlywhere the operation notes made
it clear that the surgeon had seen a distinct ovarian mass which he believed to be
the primary tumour. (The importance ofstrict criteria for the inclusion ofbiopsy
material has been argued by Meigs, 1940.) Granulosa cell tumours, theca cell
tumours, arrhenoblastomas, dysgerminomas and malignant teratomas have a
different behaviour and age distribution and have not been considered here.
The patients studied had all had an operation or a biopsy which they survived
by at least 1 month, and all were followed up for 5 years or until they died oftheir
disease. Four hundred and ninety-three cases were originally examined and
174 were rejected because they did not fulfil the criteria set out, or because the
notes or histological material were inadequate.
The stage of spread at the time of operation.-The following system of staging
was used:
Stage IA. Unilateral growth which had not penetrated the ovarian
capsule, includingthose malignant cystsruptured at operation.
Stage IB. Unilateral growth which had penetrated the ovarian capsule.
Stage IIA. Bilateral growth, in which the ovarian capsule was intact on
both sides.
Stage IIB. Bilateral growth, in which the ovarian capsule had been
penetrated, but spread elsewhere was confined to the genital
tract.
Stage IIIA. Spread to the pelvic peritoneum or viscera, but all macro-
scopicallyvisible tumourresected.
Stage IIIB. Inoperable tumour confinedto thepelvic cavity.
Stage IV. Inoperable tumourwithspread abovethepelvicbrim.
The histological type of the tumour.-The tumours were typed histologically
into three main groups; serous, mucinous and unclassified. Among the serous
tumours have been included " mesonephromas " of the adult type and endo-
metrioid tumours. The criteria for the diagnosis of endometrioid carcinomas
have been laid down by Long and Taylor (1964), but the reported incidence of
these tumours in various series ranging from from 4-8 per cent (Malloy, Dockerty,
Welch and Hunt, 1965) through 11 per cent (Schueller and Kirol, 1966), 16-7 per
cent (Long andTaylor, 1964) to 24per cent (Santesson, quotedbyLongandTaylor,
1964): confirms our experience that it is impossible to discriminate between the
poorly differentiated serous and endometrioid carcinomas. The well differentiated
endometrioid carcinomas, especially when they show squamous metaplasia, are
readily identifiable (Fig. 1), but the incidence and behaviour of endometrioid
carcinomas, throughout the whole range of differentiation, has proved impossible
to quantitate.
A recent review of " Mesonephromas " of the clear cell type or those with a
characteristic tubular pattern (Scully and Barlow, 1967) has given considerable
plausibilityto the concept thatthese represent avariant ofendometrioidcarcinoma
and their existence as a distinct entity has also been disputed by Stowe (1955)
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and Willis (1967). In any event other series (Parker, Dockerty and Randall,
1960; Novak and Woodruff, 1959; Czernobilsky, Silverman and Enterline, 1970)
suggest that their behaviour is that of serous carcinomas.
Unclassified tumours have been included in this series. There histological
appearance suggests that they are the anaplastic variants of the common serous
and endometrioid, but not mucinous, carcinomas; and this belief, which is held
by other workers (Taylor, 1959; Montgomery, 1948), has even led some (e.g.
Barzilai, 1943) to use the term " sero-anaplastic " to describe them.
The histological grade of the tumour.-In the histological grading of carcinoma
ofthe ovary problems which are inherent in any system ofgrading arise in relation
to sampling. But differences from one part of the tumour to another are not
usually marked, as the detailed study of Taylor and Long (1955) demonstrated,
and it is our experience that any one tumour tends to have a consistent growth
pattern which is reproduced in different parts of the tumour, and to a lesser
extent in metastases.
The tumours were placed in three grades, depending on their microscopic
pattern:
Grade 1. Well differentiated carcinomas, including cystic tumours with
small areas of malignant proliferation in an otherwise benign
epithelial lining.
Grade 2. Active tumours with invasion, showing complex papillary prolif-
eration, but no solidgrowth.
Grade 3. Tumours showing areas of solid growth, sometimes with necrosis.
This classification led to the inclusion of relatively more tumours in Grade 3
than in other series (Allan and Hertig, 1949; Kent and McKay, 1960). But the
inclusion of only " the wildly anaplastic " (Allan and Hertig, 1949) tumours in
Grade 3 or the establishment of a separate Grade 4 for the anaplastic tumours
(Van Orden, McAllister, Zerne and Morris, 1966) is hardly justified. Their
behaviour is no worse than the equally lethal and much commoner tumours inclu-
ded in Grade 3 inthis series.
One feature which, on this system ofgrading, could lead to error, is the misin-
terpretation of solid islands of squamous epithelium in adenoacanthomas (Fig. 2).
Following the lead of others who have discussed the presence of squamous meta-
plasia as an indication of high grade malignancy (Pemberton, 1940; Malloy et al.,
1965), solid masses of squamous epithelium were initially regarded in this survey
as a sign ofa high level ofmalignancy, but it became clear that this was erroneous,
and that the malignant potential-as in the uterine adenoacanthoma (Novak and
Nally, 1957) lies in the glandular epithelium.
Mitotic activity.-The number of mitoses per high power field was counted in
the most active area of each tumour (at a magnification of 420 times). In most
instances an average count over at least six fields was taken. Occasionally, fewer
fields had to suffice, for example in a highly necrotic tumour in which there was
only a rim of viable tissue, and also in tumours in which there was only a small
area of malignant change in an otherwise benign cyst.
In some tumours with an extensive fibrotic stroma, a large part of every high
power field was occupied by fibrous tissue. In these cases an estimate was made
ofthe number of mitoses there would have been in a cellular field, in order to give
the same percentage of mitoses. This is the method advocated and adopted by
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Bloom and Richardson (1957) in dealing with the similar problem of grading
carcinoma ofthe breast.
RESULTS AND DISCUSSION
Of the 319 women in this survey, 205 died, within 5 years of operation, and
114, or 35-7 per cent, survived for 5 years. Carcinoma ofthe ovary is not usually
a disease with a protracted course; over half the patients who succumbed did so
within 14 months ofoperation.
A wide variation in 5-year survival figures for carcinoma ofthe ovary has been
quoted by Munnell and Taylor (1949), ranging from 6-3 per cent (Walter, Bachman
and Harris (1941)to 65percentCounseller (1940). Table I summarises some recent
series and shows that a 5-year survival rate of between 20 and 40 per cent is the
usual finding.
There are three main reasons for variations in survival figures: differences in
treatment, differences in diagnosis and differences in the selection of cases.
The claims made for different forms oftreatment have been excellently reviewed
by Rubin, Grise and Terry (1962), who point out that the efficacy ofradiotherapy
or different forms of chemotherapy remains a matter for dispute.
The diagnosis of malignancy in ovarian tumours is often a matter of consider-
able difficulty, and this led Taylor (1929) to apply the term "semi-malignant "to
certain serous neoplasms. In the case of mucinous tumours, as pointed out by
Saxen and Hakama (1964), assessment may be even more contentious, despite
the work of Cariker and Dockerty (1954) in defining the criteria of malignancy.
Differences in diagnosis are not the only reasons for variation in survival figures.
Different series are frequently compared on the unstated assumption that the
patients comprise similar populations, but a brief review shows how unfounded
this assumption is. Table I shows wide variations between the number of inoper-
able cases included in each series.
TABLE I.-Somne Previous Series of Carcinoma of the Ovary
Percentage 5-year
Authors Year Cases survival Operability
Keettel, Fox, Longnecker and
Latourette 1966 . 248 . 24- 9 153 inoperable
Pomerance, Moltz and Hall 1966 124 27 89 inoperable
Van Orden, McAllister, Zerne and
Morris 1966 . 137 . 23 . 102 inoperable
Guerriero and Spiedel 1963 92 . 30 57 Stage III and IV*
Ratzkovski and Hochman
. 1963
. 70
. 21
Stone, Weingold, Sall and Sonnenblick 1963
. 131
. 20-6
Platt, Rubenstone and Hirsch 1962 89 35 63 Stage III and4V*
Kent and McKay 1960 349 36- 4 170 Stage III and IV*
Cutler, Ederer, Griswold and Greenberg 1960
. 2250
. 24
Turner, ReMine and Dockerty
. 1959
. 164 54-3
Carlin and Frodey 1957 137
. 23-3 91 inoperable
Henderson and Bean 1957 336 18- 1 195 inoperable
Munnell, Jacox and Taylor 1957 148 27 81 Stage III and IV*
Davis, Latour and Philpott 1956 202 37-6 109 Stage III and IV*
Gardiner and Slate 1956 96 32-3 67 inoperable
KerrandElkins
. 1954
. 190 31-5 91 operable
* Tumours with spread staged anatomically. In some stage III cases all visible tumour will have
been resected at operation, but the majority of stage III cases, and all stage IV cases are inoperable.
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In the current survey, the selection of cases undoubtedly operated in favour
of high survival figures, for all patients with carcinomatosis peritonei and an
uncertain primary, and all patients who died within a month of operation, were
excluded. Furthermore, hospital populations vary, because general hospitals,
specialist hospitals, and hospitals with radiotherapy departments are likely to
attract different types of patient. It was noticeable in this survey that the
Middlesex and Whittington hospitals and the Hospital for Women Soho Square
had comparable survival figures of 30 to 36 per cent, whereas the survival at
5 years at the Chelsea Hospital was 53 per cent. However, in the Chelsea Hospital
data, only 28 per cent of the patients had inoperable carcinomas, compared with
the average of 41 per cent at the other hospitals. One may surmise that similar
selection factors operate at the Mayo Clinic, from which a 54 per cent survival
has been reported (Turner et al., 1959).
The stage of spread reached at the time of operation
Table II shows the percentage survival in relation to the stage reached at
operation.
TABLE II.-Percentage Survival in Relation to Stage Reached at Operation
Percentage
Stage Operation 5 years living at 5 years
IA . 106 . 69 . 62
IB 35 . 17 . 49
IIA . 14 6 . 43
IIB . 20 . 7 . 35
IIIA . 21 . 6 . 29
IIIB . 30 . 4 . 13
IV . 93 . 5. 5
It is apparent that there are two outstanding groups. The 106 patients in
stage IA with unilateral intracapsular lesions, and the group of 93 patients where
the tumour had spread beyond the pelvis and was inoperable. The greatest
differences in the stages occur between IA and IB, on the one hand, and IIIA and
IIIB onthe other. These correspondto the differences between unilateraltumours
confined within the ovary, IA, and those which have spread to the surface of the
ovary, IB, whilst the difference between stages IIIA and IIIB, represents those
cases in which all macroscopically visible tumour was resected and those in which
residual tumour had to be left at the time ofoperation.
To correspond to these divisions, the tumours were regrouped in three stages:
Unilateral intracapsulartumours-Stage IA: 106 cases
Operable tumours withspreadbeyondthe ovarian capsule- Stage IB
to IIIA: 90 cases
Inoperable carcinomata-Stages IIIB and IV: 123 cases
The differences in survival between these three groups at 5 years are highly
significant (X2= 84, n = 2, P<0-001). They are expressed as percentages in
Fig. 3.
The theoretical advantages in using an anatomical basis for staging have been
very ably argued by Van Orden and her colleagues (1966). It leads to an objective
approach which does not depend on variations in surgical policy, and makes
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FIG. 3.-The percentage in each group surviving at yearly intervals, according to the stage
the tumour at operation.
comparison between cases more exact. If carcinoma of the ovary were a highly
radiosensitive tumour, anatomical considerations would clearly play a greater
part in staging, but the results show that the patient's survival depends to such a
large extent on the presence or otherwise of residual tumour, that a method of
staging based on operability seemed more appropriate.
The presence of ascitic fluid at operation was not taken into account in this
survey, although it is generally held to be important (e.g. Platt et al., 1962; Van
Orden et al., 1966). Malloy and his colleagues (1965) used a measure of more
than 250 ml. of ascitic fluid present at operation, but in a retrospective study
dealing with cases where ascites was not always considered important at operation,
such precision could not be achieved, and it was thought better to omit a matter
on which no accurate assessment could be made.
A separate investigation was carried out to determine the appropriate stage
of unilateral intracapsular tumours which had ruptured during removal. There
were 18 patients in this group of whom 12 (two-thirds) survived 5 years. This is
almost identical withthe 65per cent 5 yearsurvivalofthe 88women withunilateral
intracapsular lesions which had not ruptured. Such a finding has been reported
before (e.g. Malloy et al., 1965; Munnell et al., 1957), but remains surprising, in
view of the additional risk of dissemination of malignant cells.
EXPLANATION OF PLATES
FIG. 1.-A well differentiated endometroid carcinoma showing areas of squamous metaplasia.
H.& E. x100.
FIG. 2.-Solid islands of squamous epithelium in an adenoacanthoma. H. & E. x 100.
FIG. 5.-A serous carcinoma of high grade and numerous mitoses. H. & E. x 420.
FIG. 6.-A serous carcinoma very similar in pattern to that in Fig. 5 but with one mitosis per
high power field; both this and the previous figure illustrate unilateral tumours from women
in the eighth decade. The former died of recurrent tumour, whereas the latter was alive
10 years later. H. & E. x 420.
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Histological typeoftumour
In this survey the incidence ofthe various types oftumour was:
Serous 185 58per cent
Mucinous 68 21 per cent
Unclassified 66 21 per cent.
This is the pattern ofdistribution found in most series (Saxen and Hakama, 1964),
and may be taken as representative.
Fifty-three out of the 68 patients with mucinous tumours survived 5 years,
whereas only 49 ofthe 185 with serous tumours, and 12 ofthe 66 with unclassified
tumours did so. The much greater likelihood of survival for those having mucin-
ous tumours than for those with serous tumours is statistically highly significant
(X2 = 545, n = 1, P < 0X001). On the otherhand, although a smallerproportion
of patients with unclassified tumours survived 5 years than did those with serous
tumours, the difference is not significant (X2 - 1X82, n - 1, 0-2 >P >0.1).
TABLE III.-The Total Number ofCases inEachStagewith, in Brackets, the
Numbers Surviving at 5 Years
Unilateral Operable
intracapsular IB, IIA, Inoperable
Type IA IIB, IIIA IIIB, IV
Mucinous 43 (37) 14 (11) . 11 (5)
Serous 41 (28) . 55 (17) . 79 (5)
Unclassified 12 (4) . 21 (8) . 33 (0)
When the type of tumour is compared with the stage of spread (Table III)
it becomes apparent that the majority of mucinous tumours were of an early
stage, whereas there was a preponderance of inoperable tumours among the
serous and unclassified types. The relative proportions of the different histo-
logical types of tumour in the three main stages are shown in Fig. 4, which also
shows the proportion who died within 5 years of operation.
Although the better survival in the mucinous group is partly explained by the
greater numbers in the earlier stages ofdevelopment, it may be seen that there are
differences in survival within each stage between the different types of tumour.
Whilst the differences between serous and unclassified tumours are small, the
differences between serous and mucinous are significantfor unilateral intracapsular
tumours (X2 = 6'0, n = 1, P < 0.02) and for inoperable tumours (X2= 5-2,
n = 1, P < 0.05), but do not reach significance in the intermediate group of
operable tumours with spread beyond the ovarian capsule (X2 = 2'17, n = 1,
P < 0.2).
In some ways the survival figures are more disappointing than might have been
hoped, for the apparent intactness of the ovarian capsule is clearly illusory.
Microscopic spread must have already occurred in nearly half the serous and in
the majority ofthe unclassified carcinomas which at operation were thought to be
unilateral andintracapsular.
Serous and unclassified cancers behave very similarly at each stage, and the
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FIC1T. 4,--The numbers of tumours of each histological tyTpe in each stage. The hatched areas
give the number of patients wrho died within a years of operation.
results suggest very strongly that the inherent malignancy of these tumours is of
overriding importance in their prognosis at every stage.
T'he hi8tological grade of the tumnour
The distribution of the cases according to their grade is shown in Table IN".
TABLE 117.-The Di8tributioa of Ca8e8 and Their 5-Year Survival According
to Grade
Total at 5-year
Giade3 operation survivors pe3rcentage?
I 67 . 53 . 7
2 . 116 . 45S 39
3 . 136 . 6 . 12
The differeiices in 5-year survival betweeii the three groups is highly significant
(x2
= 87-2,n
= 2,P<0-000).
It vvould have been possible, by using different criteria, to have a meore equal
distribution of cases. But the relative paucity of cases in grade I and the excess
of cases in grade 3 merely underlines the fact that carcinoma of the ovary is a
highlv malignant tumour, from which relatively few women survive.
Comparison of the grade of the tumour with the stage of the spread revealed,
perhaps not surprisingly, that witbh few exceptions the more advanced the tumzour,
the les.s well differentiated it was. WVhen the type of tumour was compared with
grade, it was found that the majority of mucinous tumours were of grade I and
the majority of unclassified tumours ofgrade 3. The serous tumours, apart from
13 per cent ofgrade I, were divided equally between grades 2 and 3. This, once
again, shows the favourable nature ofmucinous tumours and the high malignancy
of,serous a.nd unclassified ones.
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The mitotic count and nuclear atypicality
The system of grading described above depends on the pattern of the tumour
seen, for the mostpart, underthe low power ofthe microscope. Cellular atypicality
and the frequency of mitosis, on the other hand, are features of the high power
magnification. They were examined separately.
It was found on reviewing these carcinomas, that, apart from mitotic activity,
the presence ofnuclear atypicality is not a useful guide to the degree ofmalignancy.
The groupings it encourages are few and there is a large indistinct borderland
between the different groups. The well differentiated tumours are made up of
cells with small nuclei, which are regular in shape and have inconspicuous nucleoli,
and the few anaplastic tumours are composed of extremely bizarre cells with gross
cellular atypia. All the tumours between these two extremes have minute grada-
tions from the small and regular to the large reticular nucleus with a pronounced
nucleolus. Accurate measurement of the size of the nucleolus, and its properties,
shown by various histochemical techniques, have been discussed by Taylor and
Long (1955), and have been found in their hands to be useful indicators of malig-
nancy. But the techniques and methods required make it impossible for such
methods ever to be used routinely, and without them the accurate assignment of
tumours to different groups is impossible.
Counting the number ofmitoses per high power field allows a much greater
degree of precision than can be reached by considerations of atypicality. It
was shown by Evans (1926) that tissues can remain unfixed for up to 24 hours
without affecting the mitoses seen, so that even the interior of large malignant
ovarian cysts gives a representative picture of the mitotic activity. By using
such a system of counting, one can be confident of a greater degree of accuracy in
assigning the tumours to four groups depending on their mitoses than into three
groups based on the degree ofnuclear atypicality.
Mitotic activity in ovarian carcinomas is not striking. In this study few
tumours were found which had more than five mitoses per high power field, and
very few had more than eight. The striking feature was the lack of mitoses even
in poorly differentiated cancers. This observation was confirmed by Van Orden
et al. (1966) who observed
"a surprising finding was the paucity of tumours which
had shown an increased number of mitoses ... Only 13 per cent had mitoses as
a prominent feature
" It conflicts, however, with the reports of Novak and
Woodruff (1967), which appeared after our study had been largely completed.
In the former study, the only one which has given numerical expression to an
appraisal of mitotic activity in ovarian carcinomas, there was agreement with
our observations that the number of mitoses correlated with the patient's chance
of survival. In contrast with our findings and those of Van Orden et al. (1966),
Novak and Woodruff reported a nigh number of mitoses in most tumours. It is
probable that the procedure adopted was different from our method, where only
cells in prophase and metaphase were counted, and, more important, where an
average count of several fields in the most active area was taken. It is obviously
easy to arrange a section in such a way that a particular field contains many more
than the average number of mitoses for the tumour, and to count the number of
of mitoses in the worst field. This would have been an alternative approach to
the investigation, and probably the one adopted by Novak and Woodruff.
It was found that the presence of an average of three or more mitoses per high
power field (see Fig. 5), gave a uniformly poor prognosis:
1) f PJ. L. DYSON, J. 0. W. BILBY AND S. J. STEELE
5-year
Mitoses Cases survivors
3/h.p.f. 46 2
4/h.p.f. 40 3
5 ormore/h.p.f. 36 3
Accordingly patients having tumours with three or more mitoses per high power
field were amalgamated into one group, and when the tumours were classified
in this way the following results were obtained:
5-year
Mitoses Cases survivors Percentage
<1/h.p.f. 47 45 96
1/h.p.f. 89 45 51
2/h.p.f. 61 15 25
>2/h.p.f. 122 8 7
The 5-year survival figures for the patients with tumours ofthree or more mitoses
was significantly worse than those in patients with two (X2 = 12-03, n = 1,
P < 0.001). Even with two mitoses the majority ofpatients died, but with only
one mitosis the numbers were almost evenly divided, and with an average of less
than one mitosis as in Fig. 6, almost all the patients lived. The difference in
survival of patients with two mitoses and with one mitosis is highly significant
(x2 = 10X2, n = 1, P < 0.01); so also is the difference between one and less than
onemitosis(X2 = 154,n = 1,P < 0001).
When the mitotic count was compared with the other ways of assessing the
tumours goodcorrelations occurred.
(i) With regard to the stage reached at operation it was found that the unilat-
eral intracapsular tumours had one, or less than one mitosis per high power field
in 71 per cent ofthe cases. The operable tumours in stages IB to IIIA were fairly
evenly spread, although with a relative lack of cases with less than one mitosis
per high power field. In the highly malignant inoperable group, the majority
showed three or more mitoses per high power field.
Evaluation of mitoses may also be useful in the cases of doubtful or border-
line malignancy. Only two women died whose tumours had less than one mitosis
per high power field, and in both cases the tumours were clinically malignant with
spread.
(ii) A comparison ofthe mitotic count with the histological type ofthe tumour
largely accounts for the superior survival figures ofpatients with mucinous carcin-
omas. Forty-five per cent had less than one mitosis per high power field, and only
a quarter had two or more. By contrast, 43 per cent of serous, and 61 per cent
ofunclassified tumours hadthree or more mitoses per high power field. Classifica-
tion by mitotic activity also explains the relatively benign behaviour of the
adenoacanthoma (Fig. 2), since allinthis series had few mitoses.
(iii) There is, not surprisingly, very great interdependence between the mitotic
count and the grade of the tumour. They are, after all, two ways of expressing
the histological malignancy ofa carcinoma. In our series it was found that there
were 245 patients in Grade 1 and Grade 3, and 30 ofthem behaved anomalously-
that is, they died oftumours ofGrade 1 or lived with tumours ofGrade 3. There
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were on the other hand 224 patients whose tumours had an average of less thar
one or more than two mitoses per high power field, and only 10 of them behavec
anomalously. The intermediate zone is larger when classifying by mitoses bul
from these results it seems that that disadvantage is more than outweighed by th(
muchgreater accuracy inprognostication.
CONCLUSIONS
This survey has shown that the prognosis in carcinoma ofthe ovary is affectec
by the stage, type, grade and mitotic activity of the tumour.
(i) The stage of the tumour at operation: This has been shown to be highl;
significant in survival, and radiotherapy and chemotherapy hold out little hop(
if not all visible tumour is resected at the time of operation. Since resectabilit3
is a crucial factor in the patient's survival this has been given due weight b3
adopting a system ofstagingbased onthe operability ofthe tumour.
The other point which this staging system has emphasised is the importance
ofthe intactness ofthe ovarian capsule. It is to some extent illusory, since there
must have been microscopic penetration in the women with unilateral intra
capsular tumours who died of carcinoma of the ovary. Nevertheless it is th(
only stage which carries a better than 50 per cent chance of survival, so it ih
important that women whose tumours are of this stage should be marked oul
as having a better than average prognosis.
(ii) The histological type ofthe tumour: The discussion in this survey has beer
centred on the relatively favourable mucinous carcinomas, although mention ha,
also been made of those endometrioid carcinomas whose low grade is signalled by
the development of squamous metaplasia. The demarcation of these tumours
however, only serves to emphasise the bleak outlook for the majority of patients
with ovarian carcinoma, for most tumours are serous or unclassified and they are
usuallyhighly malignant.
(iii) The histological grade of the tumour: The histological grade has been
shown to be related, to a great extent, to the stage ofspread, and to a lesser extent
to the histological type. It is revealed as a reliable indicator of the patient's
prognosis-in fact a more sensitive means of discrimination than the stage ol
spread. Admittedly, the largest group of women had grade 3 tumours and only
21 per cent had grade 1 tumours, but most women with carcinoma of the ovary
do die, and any attempt to balance the numbers by adopting different criteria foi
the various grades would only have diminished the usefulness of the distinctions
between them.
(iv) The mitotic count: There is a highly significant degree of correlation be-
tween the mitotic count and survival. It corresponds closely with the grade ol
the tumour, and correlates with the stage, and to some extent with the type ol
the tumour. Although patients with mucinous carcinomas do better than those
with serous or unclassified tumours for all mitotic counts, when adjustments are
made for the generally earlier stage of mucinous carcinomas this superiority dis-
appears. Thus, by using the mitotic count one may assess the malignant poten-
tial of a tumour without reference to its histological type. This has obvious
advantages in a field as confused as the histological typing of ovarian carcinomas
is at the moment. It also evades the difficulties inherent in having a class ol
unclassifiedtumours.
Comparison of the mitotic count with grading shows that to some extent
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theyproduce similar results since they are both ways ofassessing the rate ofgrowth
of a tumour. However, a third way of assessing malignancy-the degree of
cellular atypicality apart from mitoses-was not found helpful in this survey.
A mitotic count has the advantage over grading that it is easy to put into
practice and is readily reproducible from time to time and person to person.
Furthermore, it does not need previous agreement on the criteria for different
grades (a problem which, as has been shown, bedevils grading). Both grading and
mitotic activity give a fairly reliable guide to the behaviour of the majority of
tumours (those in grades 1 and 3, and those with less than one or more than two
mitoses) but the guidance from the mitotic count has the advantage that it is
surer and less liable to prove fallible. Using the count of mitoses it is possible
to predict with a good degree of accuracy the likely outcome for any woman
with an ovarian carcinoma.
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